Chronic asthenia in patients who have undergone endocrine neck surgery.
Asthenia
Parathyroidectomy
Quality of life
Thyroidectomy
Journal
Endocrine
ISSN: 1559-0100
Titre abrégé: Endocrine
Pays: United States
ID NLM: 9434444
Informations de publication
Date de publication:
Jan 2022
Jan 2022
Historique:
received:
01
02
2021
accepted:
19
07
2021
pubmed:
9
8
2021
medline:
23
3
2022
entrez:
8
8
2021
Statut:
ppublish
Résumé
The impact of chronic asthenia after thyroidectomy has been evaluated in two previous studies comparing total thyroidectomy and hemithyroidectomy. We compared its impact on patients undergoing thyroidectomy, parathyroidectomy for primary hyperparathyroidism, and cholecystectomy. Patients recruited for surgery (233 consecutive total thyroidectomies for non-toxic multinodular goiter, Group I, 43 consecutive parathyroidectomies for primary hyperparathyroidism, group II and a sample of 43 laparoscopic cholecystectomies, group III) were compared at three times: pre-operative, 6 months after surgery, 1 year after surgery. A brief fatigue inventory (BFI) was administered to assess asthenia. We excluded intermediate or high-risk thyroid carcinomas, Grave's disease, obese patients, secondary and tertiary hyperparathyroidism, vitamin D deficiency, and acute cholecystitis. In the postoperative period, patients who had undergone complications of each surgical procedure were also excluded. Demographics, smoking, alcohol abuse, chronic diseases (renal, cardiac, pulmonary, hepatic, and diabetes mellitus), anxiety and depression were noted. In Group I the significant increase of asthenia during the three periods of detection (p < 0.001) was confirmed. Renal failure further increased the risk of asthenia. In Group II, asthenia after 6 months and 1 year after surgery decreased significantly (p < 0.001). In Group III, the variations in BFI during the three periods were not significant. Asthenia is a frequent sequela of total thyroidectomy, also in comparison with other types of surgery. Patients undergoing thyroidectomy must be informed of the possible implications of surgery, which should be calibrated on the strict application of guidelines.
Identifiants
pubmed: 34365588
doi: 10.1007/s12020-021-02838-3
pii: 10.1007/s12020-021-02838-3
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
159-168Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
K.A. Donovan, P.B. Jacobsen, The Fatigue Symptom Inventory: a systematic review of its psychometric properties. Support Care Cancer 19, 169–185 (2011)
C.D. Adkisson, L. Yip, M.J. Armstrong, M.T. Stang, S.E. Carty, K.L. McCoy, Fibromyalgia symptoms and medication requirements respond to parathyroidectomy. Surgery 156(6), 1614–1621 (2014)
pubmed: 25456962
M. Cortes Rivera, C. Mastronardi, C.T. Silva-Adana, M. Arcos-Burgos, B.A. Lindbury, Myalgic encephalomyelitis/chronic fatigue syndrome: a comprehensive review. Diagnostics 9, 91 (2019). https://doi.org/10.3390/diagnostics9030091
doi: 10.3390/diagnostics9030091
pmcid: 6787585
J.H. Friedman, R.G. Brown, C. Comella et al. Working Group on Fatigue in Parkinson’s Disease. Fatigue in Parkinson’s disease. Mov. Disord. 22(3), 297–308 (2007)
pubmed: 17133511
J. Finsterer, S.Z. Mahjoub, Fatigue in healthy and diseased individuals. Am. J. Hosp. Palliat. Care (2014). https://doi.org/10.1177/1049909113494748
M.P. Davis, D. Walsh, Mechanisms of fatigue. J. Support Oncol. 8(4), 164–174 (2010)
pubmed: 20822034
M. Gonzàlez-Izal, A. Malanda, E. Gorostiaga, M. Izquierdo, Electromyographic models to assess muscle fatigue. J. Electromyogr. Kinesiol. 22(4), 501–512 (2012)
pubmed: 22440555
B.M. Kluger, L.B. Krupp, R.M. Enoka, Fatigue and fatigability in neurologic illnesses: proposal for a unified taxonomy. Neurology 80(4), 409–416 (2013)
pubmed: 23339207
pmcid: 3589241
A. Glaus, R. Crow, S.A. Hammond, Qualitative study to explore the concept of fatigue/tiredness in cancer patients and in healthy individuals. Support Care Cancer 4, 82–96 (1996)
pubmed: 8673356
D.M. Irvine, L. Vincent, N. Bubela, L. Thompson, J.E. Graydon, A critical appraisal of the research literature investigating fa- tigue in the individual with cancer. Cancer Nurs. 14(4), 188–199 (1991)
pubmed: 1913633
S. Kelley, Endocrinology update: thyroid disorders. FP Essent. 451, 11–16 (2016)
J.P. Bilerzikian, N.E. Cusano, A.A. Khan, J.M. Liu, C. Marcocci, F. Bandeira, Primary hyperparathyroidism. Nat. Rev. Dis. Primers 2, 16033 (2017). https://doi.org/10.1038/nrdp.2016.33
doi: 10.1038/nrdp.2016.33
E.S. van der Valk, L.C. Smans, H. Hofstetter, J.H. Stubbe, M. de Vries, F.J. Backx, A.R. Hermus, P.M. Zelissen, Decreased physical activity, reduced QoL and presence of debilitating fatigue in patients with Addison’s disease. Clin. Endocrinol. 85(3), 354–360 (2016). https://doi.org/10.1111/cen.13059
doi: 10.1111/cen.13059
L. Rosato, F. Pacini, S.L. Panier, G. Mondini, A. Ginardi, M. Maggio, M.C. Bosco, Della Pepa: post-thyroidectomy chronic asthenia: self-deception or disease? Endocrine 48, 615–620 (2015)
pubmed: 25033997
G. Scerrino, G. Melfa, C. Raspanti, A. Attard, S. Mazzola, R. Gullo, S. Bonventre, M. Attard, G. Cocorullo, G. Gulotta, The prevalence of post-thyroidectomy chronic asthenia: a prospective cohort study. Langenbecks Arch. Surg. 402(7), 1095–1102 (2017)
pubmed: 28299450
WHO Obesity: preventing and managing the global epidemic. Report of WHO consultation. WHO technical report series 894. World Health Organization, Geneva (2000).
G. Scerrino, G. Morfino, N.C. Paladino, V. Di Paola, E. Amodio, G. Gulotta, S. Bonventre, Does thyroid surgery for Graves’ disease improve health-related quality of life? Surg. Today 43(12), 1398–1405 (2013)
pubmed: 23229839
American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 33(Suppl. 1), s62–s69 (2010)
pmcid: 2797383
C. Raphael, C. Briscoe, J. Davies, Z.I. Whinnett, C. Manisty, R. Sutton, J. Mayet, D.P. Francis, Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure. Heart 93, 476–482 (2007)
pubmed: 17005715
R.A. Pauwels, A.S. Buist, P.M.A. Calverley, C.R. Jenkins, S.S. Hurd, Global strategy for the diagnosis, management, and preven- tion of chronic obstructive pulmonary disease. NHLBI/WHO Global initiative for chronic obstructive lung disease (GOLD). Workshop summary. Am. J. Respir. Crit. Care Med. 163, 1256–1276 (2001)
pubmed: 11316667
F. Durand, D. Valla, Assessment of prognosis of cirrhosis. Semin. Liver Dis. 28(1), 110–122 (2008)
pubmed: 18293281
C. Bauer, M.L. Melamed, T.H. Hostetter, Staging of chronic kidney disease: time for a course correction. J. Am. Soc. Nephrol. 19, 844–846 (2008)
pubmed: 18385419
S.M. McCallum, P.J. Batterham, A.L. Calear, M. Sunderland, N. Carragher, D. Kazan, Associations of fatigue and sleep disturbance with nine common mental disorders. J. Psychosom. Res. 123, 109727 (2019). https://doi.org/10.1016/j.jpsychores.2019.05.005
doi: 10.1016/j.jpsychores.2019.05.005
pubmed: 31376877
D. Quattrone, M. Di Forti, C. Gayer-Anderson, L. Ferraro, H.E. Jongsma, G. Tripoli, C. La Cascia, D. La Barbera, I. Tarricone, D. Berardi, A. Szöke, C. Arango, A. Lasalvia, A. Tortelli, P.M. Llorca, L. de Haan, E. Velthorst, J. Bobes, M. Bernardo, J. Sanjuán, J.L. Santos, M. Arrojo, C.M. Del-Ben, P.R. Menezes, J.P. Selten, E.U.-G.E.I.W.P.2 Group, P.B. Jones, J.B. Kirkbride, A.L. Richards, M.C. O’Donovan, P.C. Sham, E. Vassos, B.P. Rutten, O.S.J. van, C. Morgan, C.M. Lewis, R.M. Murray, U. Reininghaus, Transdiagnostic dimensions of psychopathology at first episode psychosis: findings from the multinational EU-GEI study. Psychol. Med. 49(8), 1378–1391 (2019)
pubmed: 30282569
R.L. Spitzer, K. Kroenke, J.B.W. Williams, B. Lowe, A brief measure for assessing generalized anxiety disorder. Arch. Intern. Med. 166, 1092–1097 (2006)
pubmed: 16717171
M. Hamilton, Hamilton depression rating scale (HAM-D). J. Neurol. Neurosurg. Psychiatry 23, 56–62 (1960)
pubmed: 14399272
pmcid: 495331
T.R. Mendoza, X.S. Wang, C.S. Cleeland, M. Morrissey, B.A. Johnson, J.K. Wendt, S.L. Huber, The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer 85(5), 1186–1196 (1999)
pubmed: 10091805
X. Huang, W. Zhou, Y. Zhang, Features of fatigue in patients with early-stage non-small cells lung cancer. J. Res. Med. Sci. 20, 268–272 (2015)
pubmed: 26109974
pmcid: 4468232
L.O. Farnebo, Primary hyperparathyroidism. Update on pathophysiology, clinical presentation and surgical treatment. Scand. J. Surg. 93, 282–287 (2004)
pubmed: 15658669
Consensus development conference statement. J. Bone Miner. Res. 6, S9–S13 (1991). https://doi.org/10.1002/jbmr.5650061406
J.L. Pasieka, L.L. Parsons, L.J. Demeure, S. Wilson, P. Malycha, J. Johns, B. Krzywda, Patient-based 131313 surgical outcome tool demonstrating alleviation of symptoms following parathyroidectomy in patients with hyperparathyroidism. World J. Surg. 26, 942–949 (2002)
pubmed: 12016473
L.A. Mack, J.L. Pasieka, Asymptomatic primary hyperparathyroidism: a surgical perspective. Surg. Clin. N. Am. 84, 803–816 (2004)
pubmed: 15145236
M.S. Eigelberger, W.K. Cheah, P.H. Ituarte, L. Streja, Q.Y. Duh, O.H. Clark, The NIH criteria for parathyroidectomy in asymptomatic primary hyperparathyroidism: are they too limited? Ann. Surg. 239(4), 528–535 (2004)
pubmed: 15024314
pmcid: 1356258
J.P. Bilezikian, M.L. Brandi, R. Eastell, S.J. Silverberg, R. Udelsman, C. Marcocci, J.T. Potts Jr, Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J. Clin. Endocrinol. Metab. 99(10), 3561–3569 (2014)
pubmed: 25162665
pmcid: 5393490
A.A. Khan, D.A. Hanley, R. Rizzoli, J. Bollerslev, J.E. Young, L. Rejnmark, R. Thakker, P. D’Amour, T. Paul, S. Van Uum, M.Z. Shrayyef, D. Goltzman, S. Kaiser, N.E. Cusano, R. Bouillon, L. Mosekilde, A.W. Kung, S.D. Rao, S.K. Bhadada, B.L. Clarke, J. Liu, Q. Duh, E.M. Lewiecki, F. Bandeira, R. Eastell, C. Marcocci, S.J. Silverberg, R. Udelsman, K.S. Davison, J.T. Potts Jr, M.L. Brandi, J.P. Bilezikian, Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and International Consensus. Osteoporos. Int. 28(1), 1–19 (2017)
pubmed: 27613721
A.D. Demir, A review of parathyroid mass and patients with nonspecific complaints. J. Int. Med. Res. 48(1), 1–6 (2020)
B.L. Solomon, M. Schaaf, R.C. Smallridge, Psychologic symptoms before and after parathyroid surgery. Am. J. Med. 96, 101–106 (1994)
pubmed: 8109593
D.S. Rao, E.R. Phillips, G.W. Divine, G.B. Talpos, Randomized controlled clinical trial of surgery versus no surgery in pa- tients with mild asymptomatic primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 89, 5415–5422 (2004)
pubmed: 15531491
J. Bollerslev, S. Jansson, C.L. Mollerup et al. Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J. Clin. Endocrinol. Metab. 92, 1687–1692 (2007)
pubmed: 17284629
E. Ambrogini, F. Cetani, L. Cianferotti et al. Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J. Clin. Endocrinol. Metab.92, 3114–3121 (2007)
pubmed: 17535997
K. Zanocco, Z. Butt, D. Kaltman, D. Elaraj, D. Cella, J.L. Holl, C. Sturgeon, Improvement in patient-reported physical and mental health after parathyroidectomy for primary hyperparathyroidism. Surgery 158(3), 837–845 (2015)
pubmed: 26032828
F. Goglia, Biological effects of 3,5 - Diiodotironine (T2). Biochemistry 70(2), 164–172 (2005)
pubmed: 15807655
R. Senese, F. Cioffi, P. de Lange, F. Goglia, A. Lanni, Thyroid: biological actions of ‘nonclassical’ thyroid hormones. J. Endocrinol. 221, R1–R12 (2014)
pubmed: 24464019
M.G. Castagna, M. Dentice, S. Cantara, R. Ambrosio, F. Maino, T. Porcelli et al. DIO2 Thr92Ala reduces deiodinase-2 activity and serum-T3 levels in thyroid-deficient patients. J. Clin. Endocrinol. Metab. 102, 1623–1630 (2017)
pubmed: 28324063
S. Jo, T.L. Fonseca, B.M.L.C. Bocco, G.W. Fernandes, E.A. McAninch, A.P. Bolin et al. Type 2 deiodinase polymorphism causes ER stress and hypothyroidism in the brain. J. Clin. Investig. 129, 230–245 (2019)
pubmed: 30352046
W.M. Wiersinga, L. Duntas, V. Fadeyev, B. Nygaard, M.P. Vanderpump, 2012 ETA guidelines: the use of L-T4 + L-T3 in the treatment of hypothyroidism. Eur. Thyroid J. 1, 55–71 (2012)
pubmed: 24782999
pmcid: 3821467
S.J. Peterson, A.R. Cappola, M.R. Castro, C.M. Dayan, A.P. Farwell, J.V. Hennessey et al. An online survey of hypothyroid patients demonstrates prominent dissatisfaction. Thyroid 28, 707–721 (2018)
pubmed: 29620972
pmcid: 6916129
M. De Oliveira, L.S. Mathias, B.M. Rodrigues, B.G. Mariani, J.B. Graceli, M.T. De Sibio, R.M. Castro Olimpio, F.C. Fontes Moretto, I.C. Deprá, C.R. Nogueira, The roles of triiodothyronine and irisin in improving the lipid profile and directing the browning of human adipose subcutaneous cells. Mol. Cell. Endocrinol. 15, 506 (2020). https://doi.org/10.1016/j.mce.2020.110744
doi: 10.1016/j.mce.2020.110744
Biondi B., Bartalena L., Chiovato L., Lenzi A., Mariotti S., Pacini F., Pontecorvi A., Vitti P., Trimarchi F., Recommendations for treatment of hypothyroidism with levothyroxine and levotriiodothyronine: a 2016 position statement of the Italian Society of Endocrinology and the Italian Thyroid Association. J. Endocrinol. Investig. (2016). https://doi.org/10.1007/s40618-016-0511-z
Acuña-Castroviejo D., Escames G., Venegas G., Dìaz-Casado M.E., Lima-Cabello E., López L.C., Rosales-Corral S., Tan D.-X., Reiter R.J., Extrapineal melatonin: sources, regulation, and potential functions. Cell. Mol. Life Sci. (2014). https://doi.org/10.1007/s00018-014-1579-2
J.P. Bilerzikian, N.E. Cusano, A.A. Khan, J.M. Liu, C. Marcocci, F. Bandeira, Primary hyperparathyroidism. Nat. Rev. Dis. Primers 2, 16033 (2017). https://doi.org/10.1038/nrdp.2016.33
doi: 10.1038/nrdp.2016.33
E.T. Diniz et al. Primary hyperparathyroidism is associated with subclinical peripheral neural alterations. Endocr. Pract. 19, 219–225 (2013)
pubmed: 23337140
G.B. Talpos et al. Randomized trial of parathyroidectomy in mild asymptomatic primary hyperparathyroidism: patient description and effects on the SF-36 health survey. Surgery. 128, 1013–1020 (2000)
pubmed: 11114637